MARA Holdings
MARA
Coinbase
COIN
Meta Platforms
META
Vale SA
VALE
Alphabet-C
GOOG
US Stock MarketDetailed Quotes
AMLX Amylyx Pharmaceuticals
- 3.575
- +0.015+0.42%
Trading Jan 24 12:57 ET
306.34MMarket Cap-0.94P/E (TTM)
3.630High3.450Low344.75KVolume3.560Open3.560Pre Close1.22MTurnover0.63%Turnover Ratio5.11P/E (Static)85.69MShares19.94952wk High1.56P/B195.52MFloat Cap1.57552wk Low--Dividend TTM54.69MShs Float41.930Historical High--Div YieldTTM5.06%Amplitude1.575Historical Low3.541Avg Price1Lot Size
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Amylyx Pharmaceuticals Stock Forum
Amylyx Pharmaceuticals Announces FDA Has Lifted the Clinical Hold on AMX0114 Phase 1 Clinical Trial for the Treatment of Amyotrophic Lateral Sclerosis
Amylyx Pharmaceuticals (NASDAQ: AMLX) announced that the FDA has lifted the clinical hold on its Phase 1 clinical trial of AMX0114, an antisense oligonucleotide targeting calpain-2 for ALS treatment. The company will proceed with opening U.S. sites for screening, enrollment, and dosing.
The Phase 1 LUMINA cl...
No comment yet